[IJM] QoQ Annualized Quarter Result on 31-Dec-2022 [#3]

Stock
[IJM] IJM CORPORATION BHD
Announcement Date
23-Feb-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2023
Quarter
31-Dec-2022 [#3]
Profit Trend
QoQ- 49.17%
YoY- -82.96%
Quarter Report
Latest QR
Upcoming QR
IJM's Result
IJM's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 5,368,366 4,903,304 4,572,485 4,327,600 4,289,268 4,290,920 4,408,980 14.01%
PBT 742,274 720,488 483,028 437,037 360,056 364,840 317,871 75.92%
Tax -287,702 -261,052 -271,432 -195,686 -176,018 -169,296 567,333 -
NP 454,572 459,436 211,596 241,350 184,038 195,544 885,204 -35.84%
-
NP to SH 388,658 402,568 158,275 180,300 120,872 133,624 794,890 -37.90%
-
Tax Rate 38.76% 36.23% 56.19% 44.78% 48.89% 46.40% -178.48% -
Total Cost 4,913,794 4,443,868 4,360,889 4,086,249 4,105,230 4,095,376 3,523,776 24.79%
-
Net Worth 9,853,200 9,764,508 9,836,125 9,811,051 9,870,265 9,814,611 10,066,664 -1.41%
Dividend
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Div 140,259 - 281,032 93,773 141,003 - 752,313 -67.33%
Div Payout % 36.09% - 177.56% 52.01% 116.66% - 94.64% -
Equity
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Net Worth 9,853,200 9,764,508 9,836,125 9,811,051 9,870,265 9,814,611 10,066,664 -1.41%
NOSH 3,647,566 3,647,566 3,647,566 3,647,566 3,647,566 3,647,566 3,645,488 0.03%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 8.47% 9.37% 4.63% 5.58% 4.29% 4.56% 20.08% -
ROE 3.94% 4.12% 1.61% 1.84% 1.22% 1.36% 7.90% -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 153.10 139.60 130.16 123.07 121.68 121.54 123.07 15.65%
EPS 11.08 11.48 4.49 5.12 3.42 3.80 22.19 -37.03%
DPS 4.00 0.00 8.00 2.67 4.00 0.00 21.00 -66.86%
NAPS 2.81 2.78 2.80 2.79 2.80 2.78 2.81 0.00%
Adjusted Per Share Value based on latest NOSH - 3,647,566
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 147.18 134.43 125.36 118.64 117.59 117.64 120.87 14.01%
EPS 10.66 11.04 4.34 4.94 3.31 3.66 21.79 -37.88%
DPS 3.85 0.00 7.70 2.57 3.87 0.00 20.63 -67.30%
NAPS 2.7013 2.677 2.6966 2.6898 2.706 2.6907 2.7598 -1.41%
Price Multiplier on Financial Quarter End Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 -
Price 1.86 1.49 1.60 1.60 1.67 1.73 1.67 -
P/RPS 1.21 1.07 1.23 1.30 1.37 1.42 1.36 -7.48%
P/EPS 16.78 13.00 35.51 31.21 48.70 45.71 7.53 70.52%
EY 5.96 7.69 2.82 3.20 2.05 2.19 13.29 -41.38%
DY 2.15 0.00 5.00 1.67 2.40 0.00 12.57 -69.15%
P/NAPS 0.66 0.54 0.57 0.57 0.60 0.62 0.59 7.75%
Price Multiplier on Announcement Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 30/11/23 28/08/23 29/05/23 23/02/23 25/11/22 24/08/22 27/05/22 -
Price 1.81 1.78 1.57 1.58 1.58 1.74 1.80 -
P/RPS 1.18 1.28 1.21 1.28 1.30 1.43 1.46 -13.22%
P/EPS 16.33 15.53 34.85 30.82 46.08 45.97 8.11 59.38%
EY 6.12 6.44 2.87 3.25 2.17 2.18 12.33 -37.28%
DY 2.21 0.00 5.10 1.69 2.53 0.00 11.67 -66.98%
P/NAPS 0.64 0.64 0.56 0.57 0.56 0.63 0.64 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment